Neurogastrx, Inc.
WOBURN, MA · Founded 2017 · CIK 0001870700 · Biotech · Private
Biopharmaceutical therapeutics for gastrointestinal diseases
neurogastrx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $80M
- 2 Form D · Jul 2021
- 63 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 26
- 7 granted · 19 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $20,000,000 | |
| Private capital raised | Form D · SEC | $60,000,002 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1786 | SmartLife, Inc. | — | $225K |
| 1787 | Evofem Biosciences, Inc. | — | $86M |
| 1788 | AGILE THERAPEUTICS INC | — | $81M |
| 1789 | Neurogastrx, Inc. | — | $80M |
| 1790 | Azafaros | — | — |
| 1791 | Faknostics, LLC | — | — |
| 1792 | Green Growth Brands Inc. | — | $17M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- DAVID ALLISONDirector
- CYRIL DE COLLEDirector · Executive Officer
- JAMES DETOREExecutive Officer
- KEVIN KOCHDirector
- JAMES O'MARADirector · Executive Officer
- PAUL ROGERSExecutive Officer
- AARON ROYSTONDirector
- KLAUS VEITINGERDirector
- KLAUS VETTINGERDirector
Patents
- Methods Of Metabolizing Metopimazine And Its Saltsapplication
- Methods For Treating Gi Tract Disordersapplication
- Polymorphic Forms Of Metopimazinegranted
- Novel Polymorphic Forms Of Metopimazineapplication
- Novel Polymorphic Forms Of Metopimazinegranted
- Methods For Treating Gi Tract Disordersapplication
- Methods For Treating Gi Tract Disordersgranted
- Novel Polymorphic Forms Of Metopimazinegranted
- Methods For Treating Gi Tract Disordersapplication
- Methods For Treating Gi Tract Disordersapplication
- Prodrugs Of Metopimazinegranted
- Methods For Treating Gi Tract Disordersgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.